Lisata Therapeutics

Lisata Therapeutics

Quarterly Financials

Values in thousands2026-09-302026-06-302026-03-312025-12-31
Revenue
$0
$0
$0
$100
Gross Profit
-4
-3
-2
100
EBITDA
-10,026
-3,989
-4,874
-2,939
EBIT
-10,030
-3,992
-4,876
-2,954
Net Income
-6,787
-2,929
-4,489
-2,954
Net Change In Cash
0
0
0
100
Free Cash Flow
-12,681
-2,649
-3,083
-3,249
Cash
282,717
10,443
13,060
15,956
Basic Shares
9,305
9,106
9,006
8,687

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$170
$1,000
$0
$121,372
Gross Profit
24
1,000
-189
63,771
EBITDA
-17,402
-20,609
-22,981
-56,635
EBIT
-17,548
-20,783
-23,170
-56,704
Net Income
-16,586
-19,985
-20,840
-54,225
Net Change In Cash
170
1,000
0
121,372
Free Cash Flow
-15,977
-19,356
-20,032
-21,455
Cash
15,956
16,209
22,593
32,154
Basic Shares
8,687
8,329
8,073
5,180

Earnings Calls

QuarterEPS
2026-09-30
-$0.73
2026-06-30
-$0.54
2026-03-31
-$0.33
2025-12-31
-$0.33